Login
$IPSC
$1.42 -$0.04 (2.74%) Close

Insider Transactions

What Century Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 3
Sells 5 20
Total trades 8 41

Shares traded

3 months 12 months
Acquired 0 2,000,120
Disposed 50,793 323,535
Net activity −50,793 +1,676,585

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Russotti Gregory See Remarks Sep 14 Open-market sale · S −2,587 $1.93 −$4.99K 509,198
Carr Douglas SVP Finance & Operations Sep 14 Open-market sale · S −1,658 $1.93 −$3.2K 502,907
Pfeiffenberger Brent President and CEO Sep 11 Withheld — tax / exercise cost · F −13,850 $1.94 −$26.9K 3,633,839
Carr Douglas SVP Finance & Operations Sep 08 Open-market sale · S −254 $2.05 −$521 504,565
Russotti Gregory See Remarks Sep 08 Open-market sale · S −534 $2.05 −$1.09K 511,785
Pfeiffenberger Brent President and CEO Sep 04 Withheld — tax / exercise cost · F −463 $2.11 −$977 3,633,839
Pfeiffenberger Brent President and CEO Aug 14 Withheld — tax / exercise cost · F −31,172 $1.92 −$59.9K 3,634,302
Carr Douglas SVP Finance & Operations Aug 03 Open-market sale · S −275 $1.98 −$544 504,819
Carr Douglas SVP Finance & Operations Jun 12 Open-market sale · S −1,654 $2.23 −$3.69K 505,094
Russotti Gregory See Remarks Jun 12 Open-market sale · S −2,584 $2.23 −$5.77K 512,319
Cowan Chad Chief Scientific Officer Jun 11 Withheld — tax / exercise cost · F −358 $2.24 −$802 1,175,322
Pfeiffenberger Brent President and CEO Jun 11 Withheld — tax / exercise cost · F −13,849 $2.24 −$31K 3,665,474
Carr Douglas SVP Finance & Operations Jun 08 Open-market sale · S −249 $2.11 −$526 506,748
Russotti Gregory See Remarks Jun 08 Open-market sale · S −524 $2.11 −$1.11K 514,903
Pfeiffenberger Brent President and CEO Jun 05 Withheld — tax / exercise cost · F −463 $2.13 −$986 3,679,323
Pfeiffenberger Brent President and CEO May 15 Withheld — tax / exercise cost · F −31,172 $2.34 −$72.9K 3,679,786
Carr Douglas SVP Finance & Operations May 04 Open-market sale · S −264 $2.34 −$618 506,997
Cowan Chad Chief Scientific Officer Apr 01 Withheld — tax / exercise cost · F −1,365 $2.19 −$2.99K 1,175,680
Carr Douglas SVP Finance & Operations Mar 12 Open-market sale · S −7,043 $2.55 −$18K 507,261
Russotti Gregory See Remarks Mar 12 Open-market sale · S −10,076 $2.55 −$25.7K 515,427

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support